Stock VOX VOXEL S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Voxel S.A.

Equities

VOX

PLVOXEL00014

Market Closed - Warsaw S.E.
Other stock markets
 16:55:40 10/05/2024 BST 		5-day change 1st Jan Change
93.2 PLN +0.22% Intraday chart for Voxel S.A. +0.43% +18.58%
03-11 Amadeus IT Group Buys Voxel Media in EUR113 Million Deal MT
2023 Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Sales forecast by analysts have been recently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VOXEL S.A. Stock Voxel S.A.
+18.58% 245M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.58% 8.49B
B+
RADNET, INC. Stock RadNet, Inc.
+58.90% 4.08B
C+
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.78% 2.42B
B-
SYNLAB AG Stock SYNLAB AG
-10.33% 2.42B -
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.91% 2.33B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-2.53% 2.01B
C-
FLEURY S.A. Stock Fleury S.A.
-19.90% 1.53B
A-
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.30% 1.26B
C+
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+2.19% 1.07B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VOX Stock
  4. Ratings Voxel S.A.